Our Insights Chronic Disease Anthony Iannacci 9/2/26 Chronic Disease Anthony Iannacci 9/2/26 Cytokinetics’ Myqorzo is On Track For a Significant Label Expansion into nHCM, Where In-Class Rival Camzyos Failed. Payers are the Next Challenge. Read More Want to get in touch? Click here
Chronic Disease Anthony Iannacci 9/2/26 Chronic Disease Anthony Iannacci 9/2/26 Cytokinetics’ Myqorzo is On Track For a Significant Label Expansion into nHCM, Where In-Class Rival Camzyos Failed. Payers are the Next Challenge. Read More
